Authors:
Nathan, RA
Nayak, AS
Graft, DF
Lawrence, M
Picone, FJ
Ahmed, T
Wolfe, J
Vanderwalker, ML
Nolop, KB
Harrison, JE
Citation: Ra. Nathan et al., Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate, ANN ALLER A, 86(2), 2001, pp. 203-210
Authors:
Noonan, M
Karpel, JP
Bensch, GW
Ramsdell, JW
Webb, DR
Nolop, KB
Lutsky, BN
Citation: M. Noonan et al., Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler, ANN ALLER A, 86(1), 2001, pp. 36-43
Authors:
Nayak, AS
Banov, C
Corren, J
Feinstein, BK
Floreani, A
Friedman, BF
Goldsobel, A
Gottschlich, GM
Hannaway, PJ
Lampl, KL
Lapidus, RJ
Lawrence, M
Lumry, W
Munk, Z
Pearlman, D
Scardella, AT
Schenkel, EJ
Segal, AT
Segall, N
Silverman, B
Shneyer, L
Nolop, KB
Harrison, JE
Citation: As. Nayak et al., Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma, ANN ALLER A, 84(4), 2000, pp. 417-424
Authors:
Bousquet, J
D'Urzo, A
Hebert, J
Barraza, CH
Boulet, LP
Suarez-Chacon, R
Harnest, U
Lundback, B
Morales, GM
Nieminen, MM
Nolop, KB
Visser, S
Lutsky, BN
Citation: J. Bousquet et al., Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler (R), EUR RESP J, 16(5), 2000, pp. 808-816
Authors:
Fish, JE
Karpel, JP
Craig, TJ
Bensch, GW
Noonan, M
Webb, DR
Silverman, B
Schenkel, EJ
Rooklin, AR
Ramsdell, JW
Nathan, R
Leflein, JG
Grossman, J
Graft, DF
Gower, RG
Garay, SM
Frigas, E
DeGraff, AC
Bronsky, EA
Bernstein, DI
Berger, W
Shneyer, L
Nolop, KB
Harrison, JE
Citation: Je. Fish et al., Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related duality of life in patients with severe persistent asthma, J ALLERG CL, 106(5), 2000, pp. 852-860
Authors:
Schenkel, EJ
Skoner, DP
Bronsky, EA
Miller, SD
Pearlman, DS
Rooklin, A
Rosen, JP
Ruff, ME
Vandewalker, ML
Wanderer, A
Damaraju, CV
Nolop, KB
Mesarina-Wicki, B
Citation: Ej. Schenkel et al., Absence of growth retardation in children with perennial allergic rhinitisafter one year of treatment with mometasone furoate aqueous nasal spray, PEDIATRICS, 105(2), 2000, pp. E221-E227
Authors:
Bernstein, DI
Berkowitz, RB
Chervinsky, P
Dvorin, DJ
Finn, A
Gross, GN
Karetzky, M
Kemp, JP
Laforce, C
Lumry, W
Mendelson, LM
Nelson, H
Pearlman, D
Rachelefsky, G
Ratner, P
Repsher, L
Segal, AT
Selner, JC
Settipane, GA
Wanderer, A
Cuss, FM
Nolop, KB
Harrison, JE
Citation: Di. Bernstein et al., Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler, RESP MED, 93(9), 1999, pp. 603-612
Authors:
Berkowitz, RB
Bernstein, DI
LaForce, C
Pedinoff, AJ
Rooklin, AR
Damaraju, CRV
Mesarina-Wicki, B
Nolop, KB
Citation: Rb. Berkowitz et al., Onset of action of mometasone furoate nasal spray (NASONEX (R)) in seasonal allergic rhinitis, ALLERGY, 54(1), 1999, pp. 64-69
Authors:
Meltzer, EO
Berger, WE
Berkowitz, RB
Bronsky, EA
Dvorin, DJ
Finn, AF
Galant, SP
Grossman, J
Hampel, FC
Ratner, PH
Ruff, ME
Schenkel, EJ
Segal, AT
Segall, N
Stewart, GE
Tripathy, I
Skoner, DP
Anolik, R
Dockhorn, RJ
van Bavel, J
Mesarina-Wicki, B
Nolop, KB
Citation: Eo. Meltzer et al., A dose-ranging study of mometasone furoate aqueous nasal spray in childrenwith seasonal allergic rhinitis, J ALLERG CL, 104(1), 1999, pp. 107-114
Authors:
Frieri, M
Therattil, J
Chavarria, V
Cosachov, J
Kumar, NS
Wang, SF
Sansone, G
Etzel, J
Dellevecchia, D
Zitt, M
Mesarina-Wicki, B
Nolop, KB
Citation: M. Frieri et al., Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis, ANN ALLER A, 81(5), 1998, pp. 431-437